Dechra has a total of 147 patents globally, out of which 63 have been granted. Of these 147 patents, more than 46% patents are active. The United States of America is where Dechra has filed the maximum number of patents, followed by Europe and Brazil. Parallelly, the United States of America seems to be the main focused R&D centre and also United Kingdom is the origin country of Dechra.
Dechra was founded in the year 1997. Dechra is a global pharmaceutical company with a veterinary market focus. Its primary area of expertise is the creation and promotion of medications for companion animals. The business is divided into four segments: services, US pharmaceuticals, European pharmaceuticals, and US pharmaceuticals. As of February 2023, Dechra Pharmaceuticals has a market cap of $4.29 Billion.
Do read about some of the most popular patents of Dechra which have been covered by us in this article and also you can find Dechra patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Dechra patent portfolio.
How many patents does the CEO of Dechra have?
The CEO Ian Page have 0 patents.
How many patents does Dechra have?
Dechra has a total of 147 patents globally. These patents belong to 45 unique patent families. Out of 147 patents, 68 patents are active.How Many Patents did Dechra File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Dechra Applications Filed | Dechra Patents Granted |
| 2022 | – | 1 |
| 2021 | 3 | 18 |
| 2020 | 9 | 5 |
| 2019 | 4 | 2 |
| 2018 | 4 | 1 |
| 2017 | – | 4 |
| 2016 | 30 | 1 |
| 2015 | 2 | 1 |
| 2014 | 1 | 8 |
| 2013 | 2 | 1 |
| 2012 | 3 | 4 |
| 2011 | 3 | 2 |
How many Dechra patents are Alive/Dead?
How Many Patents did Dechra File in Different Countries?
Countries in which Dechra Filed Patents
| Country | Patent |
| United States Of America | 40 |
| Europe | 13 |
| Brazil | 10 |
| Canada | 7 |
| Japan | 6 |
| Australia | 6 |
| Mexico | 6 |
| Netherlands | 6 |
| Portugal | 5 |
| Spain | 5 |
| China | 4 |
| India | 4 |
| Denmark | 3 |
| Poland | 3 |
| Norway | 2 |
| Slovenia | 2 |
| Serbia | 2 |
| Croatia | 2 |
| Singapore | 2 |
| Malaysia | 2 |
| Germany | 2 |
| Hungary | 2 |
| Hong Kong (S.A.R.) | 1 |
| New Zealand | 1 |
| Israel | 1 |
| Lithuania | 1 |
| Italy | 1 |
Where are Research Centres of Dechra Patents Located?
10 Best Dechra Patents
US20050214349A1 is the most popular patent in the Dechra portfolio. It has received 79 citations so far from companies like Mars Incorporated, Kimberly-Clark Worldwide and Big Heart Pet.
Below is the list of 10 most cited patents of Dechra:
| Publication Number | Citation Count |
| US20050214349A1 | 79 |
| US20030235610A1 | 46 |
| US20080124385A1 | 25 |
| US6420425B1 | 23 |
| US20040115247A1 | 22 |
| US7025965B1 | 21 |
| US6610276B2 | 20 |
| EP2338493A1 | 18 |
| US20080318918A1 | 16 |
| WO2009064859A1 | 12 |
How many inventions of other companies were rejected due to Dechra patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Dechra invention. They couldn’t because Dechra had protected those before them.
Examiners at the USPTO referred 10 Dechra patents in 64 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the Dechra patent portfolio are Pacira, Luoda Pharma and Colgate-Palmolive.
List of the Companies whose Patents were rejected citing Dechra –
| Company | Number of Patent Applications that faced Rejection Citing Dechra Patents | Number of Rejections (102 & 103) |
| Pacira | 5 | 14 |
| Luoda Pharma | 2 | 2 |
| Colgate-Palmolive | 1 | 3 |
| Tfh Publications | 1 | 1 |
| Procter & Gamble | 1 | 1 |
| Crampsaway | 1 | 1 |
| University Of Queensland | 1 | 2 |
| Hill’S Pet Nutrition | 1 | 10 |
| Arms Pharmaceutical | 1 | 2 |
| Icf Srl | 1 | 1 |